human dermal primary lec Search Results


90
Lonza hmvec-dly
Hmvec Dly, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+primary+lec/pmc11592815-26-36-70?v=Lonza
Average 90 stars, based on 1 article reviews
hmvec-dly - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza primary human dermal lymphatic endothelial cells (lecs)
Primary Human Dermal Lymphatic Endothelial Cells (Lecs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+primary+lec/pm37971882-233-0-10?v=Lonza
Average 90 stars, based on 1 article reviews
primary human dermal lymphatic endothelial cells (lecs) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
ScienCell human dermal lymphatic endothelial cell (lec)
Human Dermal Lymphatic Endothelial Cell (Lec), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+primary+lec/10__1158_slash_0008___5472__can___17___1961-66-0-9?v=ScienCell
Average 90 stars, based on 1 article reviews
human dermal lymphatic endothelial cell (lec) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
AngioBio Inc human neonatal dermal lymphatic endothelial cells (lec
Suppression of vascular endothelial growth factor <t>(VEGF)‐C‐driven</t> <t>lymphatic</t> endothelial cell <t>(LEC)</t> proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).
Human Neonatal Dermal Lymphatic Endothelial Cells (Lec, supplied by AngioBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+primary+lec/pmc07657111-66-0-10?v=AngioBio+Inc
Average 90 stars, based on 1 article reviews
human neonatal dermal lymphatic endothelial cells (lec - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
ScienCell human dermal lec
Suppression of vascular endothelial growth factor <t>(VEGF)‐C‐driven</t> <t>lymphatic</t> endothelial cell <t>(LEC)</t> proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).
Human Dermal Lec, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+primary+lec/pmc11158915-68-0-6?v=ScienCell
Average 90 stars, based on 1 article reviews
human dermal lec - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza huvecs
Suppression of vascular endothelial growth factor <t>(VEGF)‐C‐driven</t> <t>lymphatic</t> endothelial cell <t>(LEC)</t> proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).
Huvecs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+primary+lec/bio_rxiv__2022__07__18__500467-165-7-16?v=Lonza
Average 90 stars, based on 1 article reviews
huvecs - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc human dermal lymphatic microvascular endothelial cells (lec)
Suppression of vascular endothelial growth factor <t>(VEGF)‐C‐driven</t> <t>lymphatic</t> endothelial cell <t>(LEC)</t> proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).
Human Dermal Lymphatic Microvascular Endothelial Cells (Lec), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+primary+lec/pmc03073416-50-16-32?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
human dermal lymphatic microvascular endothelial cells (lec) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza primary human dermal lec
Suppression of vascular endothelial growth factor <t>(VEGF)‐C‐driven</t> <t>lymphatic</t> endothelial cell <t>(LEC)</t> proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).
Primary Human Dermal Lec, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+primary+lec/pm23663736-249-0-9?v=Lonza
Average 90 stars, based on 1 article reviews
primary human dermal lec - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

N/A
Primary Human Dermal Lymphatic Endothelial Cells isolated from different sources (e.g. juvenile foreskin). CD31 positive, Podoplanin positive. Primary Human Dermal Lymphatic Endothelial Cells (HDLEC) are a subpopulation of the Human Dermal Endothelial Cells. They are
  Buy from Supplier

N/A
Primary Human Dermal Lymphatic Endothelial Cells isolated from different sources (e.g. juvenile foreskin). CD31 positive, Podoplanin positive. Primary Human Dermal Lymphatic Endothelial Cells (HDLEC) are a subpopulation of the Human Dermal Endothelial Cells. They are
  Buy from Supplier

Image Search Results


Suppression of vascular endothelial growth factor (VEGF)‐C‐driven lymphatic endothelial cell (LEC) proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).

Journal: Cancer Science

Article Title: Suppression of lymph node and lung metastases of endometrial cancer by muscle‐mediated expression of soluble vascular endothelial growth factor receptor‐3

doi: 10.1111/cas.12184

Figure Lengend Snippet: Suppression of vascular endothelial growth factor (VEGF)‐C‐driven lymphatic endothelial cell (LEC) proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).

Article Snippet: Human neonatal dermal lymphatic endothelial cells (LEC) were purchased from AngioBio (Del Mar, CA, USA) and maintained in EGM‐MV2 BulletKit (Cambrex, East Rutherford, NJ, USA) supplemented with 10% inactivated FCS at 37°C in a 5% CO 2 atmosphere.

Techniques: Expressing, Luciferase, Recombinant, Colorimetric Assay